Normal view MARC view
  • Poliovirus Vaccine, Oral

Entry Topical Term

Number of records used in: 7

001 - CONTROL NUMBER

  • control field: 280725

003 - CONTROL NUMBER IDENTIFIER

  • control field: DNLM

005 - DATE AND TIME OF LATEST TRANSACTION

  • control field: 20210314205706.0

008 - FIXED-LENGTH DATA ELEMENTS

  • fixed length control field: 990101 n ancnnbabn || ana

040 ## - CATALOGING SOURCE

  • Original cataloging agency: DNLM
  • Transcribing agency: DNLM

060 #0 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER

  • Classification number: WC 556

072 ## - SUBJECT CATEGORY CODE

  • Subject category code: D20.
  • Subject category code subdivision: 215.
  • Subject category code subdivision: 894.
  • Subject category code subdivision: 899.
  • Subject category code subdivision: 623.
  • Subject category code subdivision: 750

150 ## - HEADING--TOPICAL TERM

  • Topical term or geographic name entry element: Poliovirus Vaccine, Oral

450 ## - SEE FROM TRACING--TOPICAL TERM

  • Topical term or geographic name entry element: Sabin Vaccine

450 ## - SEE FROM TRACING--TOPICAL TERM

  • Control subfield: nnna
  • Topical term or geographic name entry element: Oral Poliovirus Vaccine

450 ## - SEE FROM TRACING--TOPICAL TERM

  • Control subfield: nnna
  • Topical term or geographic name entry element: Vaccine, Oral Poliovirus

450 ## - SEE FROM TRACING--TOPICAL TERM

  • Control subfield: nnna
  • Topical term or geographic name entry element: Vaccine, Sabin

680 ## - PUBLIC GENERAL NOTE

  • Explanatory text: A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed)
Copyright © 2025. All rights reserved.

P.O. Box 2932 1000 Manila, Philippines | Telephone: +63 2 8528 8001 | Facsimile: +63 2 8521 1036 / 5338 0314 | email: wpropostmaster@who.int
Home | Private Policy | Terms of use